Moreover, the combination of MAGI2-AS3 in PBMCs and serum CA15-3 exhibited better diagnostic performance for breast cancer (AUC = 0.940) than a single marker (Fig. 4C). This evidence concerns the gene PDS5B and breast carcinoma.